Achelios Therapeutics is Drug Delivery in United States that focus on developer business. Founded in 2012. They cover business area such as developer, pharmaceutical product, non-steroidal anti-inflammatory drug molecule, topically deliver medication, therapeutic compound development, sprain, prophylaxis, osteoarthritis, side effect, efficacy, patient, pain relief.
2012
( 12 years old in 2024 )
Developer
-
4364 South Alston Avenue
Suite 300
Durham, NC 27713
United States
Private
developerpharmaceutical productnon-steroidal anti-inflammatory drug moleculetopically deliver medicationtherapeutic compound developmentsprainprophylaxisosteoarthritisside effectefficacypatientpain relief
* We use standard office opening hours in near Achelios Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Achelios Therapeutics is Drug Delivery business from United States that founded in 2012 (12 years old in 2024), Achelios Therapeutics business is focusing on Developer.
Achelios Therapeutics headquarter office and corporate office address is located in 4364 South Alston Avenue Suite 300 Durham, NC 27713 United States.
Achelios Therapeutics was founded in United States.
In 2024, Achelios Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Achelios Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
